Dishman Carbogen Amcis enterprise value

Share price at each year-end

Tap a line for its trend	Currentlast 12M	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus


2,334	—	—	—	—	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
804	804	367	287	309
2,775	2,775	2,084	1,964	1,825
4,306	—	—	—	—
1,971	1,971	1,717	1,677	1,516
₹274.59	—	—	—	—

9,452	9,452	7,915	7,592	7,634
29.4%	29.4%	26.3%	25.9%	23.9%
0.64×	—	—	—	—

1.48×	—	—	—	—
8.88×	—	—	—	—
31.43×	—	—	—	—
19.10×	—	—	—	—
2,901	2,932	2,712	2,616	2,413
485	566	469	287	332
137	227	175	−24.4	51.5
—	491	375	384	220
225	225	158	80.7	−354
—	214	67.9	80.7	−387
—	266	217	303	574

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

DCAL₹148.86

Dishman Carbogen Amcis Limited

· Pharma & Health

₹ CrorePeersHIKAL SOLARA PANACEABIO INDSWFTLAB SAIPARENT INDOCO SMSPHARMA WINDLASMcap ₹2,334 Cr

HighlightsEnterprise Value Multiples Per ShareAnnuals · FY-end closes

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Current/LTM TTM · last close
Market Capitalization	—	—	—	—	2,334.1
- Cash, Equiv & ST Investments	308.8	287.4	366.5	803.9	803.9
+ Total Debt	1,824.5	1,964.4	2,083.9	2,775.4	2,775.4
Enterprise Value	—	—	—	—	4,305.6
Net Debt (memo)	1,515.8	1,677.0	1,717.4	1,971.5	1,971.5
EV per Share	—	—	—	—	274.59

Total Capital	7,634.2	7,591.9	7,915.4	9,452.3	9,452.3
Total Debt/Total Capital	23.90	25.87	26.33	29.36	29.36
Total Debt/EV	—	—	—	—	0.64

EV/Sales	—	—	—	—	1.48
EV/EBITDA	—	—	—	—	8.88
EV/EBIT	—	—	—	—	31.43
EV/Free Cash Flow	—	—	—	—	19.10
Reference Items — Trailing FY Values
Sales	2,412.9	2,615.8	2,711.5	2,931.9	2,901.5
EBITDA	332.2	286.5	468.9	565.6	485.0
EBIT	51.5	-24.4	175.2	226.9	137.0
Operating Cash Flow	220.3	384.0	375.2	491.5	—
Free Cash Flow	-353.7	80.7	158.5	225.5	225.5
FCFF (free cash flow to the firm)	-387.0	80.7	67.9	214.4	—
Capital Expenditure	574.1	303.3	216.8	266.0	—

Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.